ANP32A modulates cell growth by regulating p38 and Akt activity in colorectal cancer.

Authors: Yan W, Bai Z, Wang J, Li X, Chi B, Chen X Abstract Acidic leucine-rich nuclear phosphoprotein-32A (ANP32A) possesses multiple biochemical activities, has been found to be decreased or absent in malignant tumors. However, new findings have shown that it is expressed in greater amounts in advanced cancers than in early-stage tumors. The role and clinical significance of ANP32A in colorectal cancer (CRC) is still unknown. In the present study, the expression of ANP32A was assessed in 68 CRC patients by IHC, and then the correlation of its expression with clinicopathological factors was investigated using the Allred, Klein and immune response scoring system analysis. Western blot and real-time PCR analyses were used to assess ANP32A expression and the activity of Akt and p38 ...

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2vLVEka
via IFTTT